Back
Revelation Biosciences, Inc. 10K Form
Sell
31
REVB
Revelation Biosciences, Inc.
Last Price:
$1.05
Seasonality Move:
-45.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive REVB News And Ratings
See the #1 stock for the next 7 days that we like better than REVB
REVB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.07 |
| Price / Book: | 0.56 |
Profitability
| EPS (TTM): | -25.83040 |
|---|---|
| Net Income (TTM): | $-8.1M |
| Gross Margin: | $-27.9K |
| Return on Equity: | -161.98% |
| Return on Assets: | -114.22% |
Revelation Biosciences, Inc. Earnings Forecast
Key Revelation Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Revelation Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | REVB |
| Website: | revbiosciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.92 |
| Quick Ratio: | 6.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
REVB Technical Analysis vs Fundamental Analysis
Sell
31
Revelation Biosciences, Inc. (REVB)
is a Sell
Is Revelation Biosciences, Inc. a Buy or a Sell?
-
Revelation Biosciences, Inc. stock is rated a SellThe current Revelation Biosciences, Inc. [REVB] share price is $1.04. The Score for REVB is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.